Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
作者信息
Marion Olivier, Del Bello Arnaud, Abravanel Florence, Couat Chloé, Faguer Stanislas, Esposito Laure, Hebral Anne Laure, Izopet Jacques, Kamar Nassim
机构信息
Toulouse Rangueil University Hospital, Paul Sabatier University, and INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Disease (Infinity), Toulouse, France.
Toulouse Rangueil University Hospital and Paul Sabatier University, Toulouse, France.
出版信息
Ann Intern Med. 2021 Sep;174(9):1336-1338. doi: 10.7326/M21-1341. Epub 2021 May 25.
Abstract
摘要
相似文献
1
Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.实体器官移植受者中抗SARS-CoV-2信使核糖核酸疫苗的安全性和免疫原性
Ann Intern Med. 2021 Sep;174(9):1336-1338. doi: 10.7326/M21-1341. Epub 2021 May 25.
2
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.实体器官移植受者接种第三剂新冠病毒疫苗的安全性和免疫原性：病例系列
Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.
3
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.通过更换疫苗提高实体器官移植受者对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的免疫原性。
Clin Microbiol Infect. 2021 Oct;27(10):1529-1530. doi: 10.1016/j.cmi.2021.06.022. Epub 2021 Jun 27.
4
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.严重急性呼吸综合征冠状病毒2型信使核糖核酸疫苗在曾感染2019冠状病毒病的实体器官移植受者中的免疫原性
Transplantation. 2021 Nov 1;105(11):e270-e271. doi: 10.1097/TP.0000000000003900.
5
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.mRNA 疫苗在实体器官移植受者中的单剂免疫原性。
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
6
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.实体器官移植受者接种三剂mRNA新冠疫苗
N Engl J Med. 2021 Aug 12;385(7):661-662. doi: 10.1056/NEJMc2108861. Epub 2021 Jun 23.
7
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗接种的实体器官移植受者的抗体动力学和持久性
Transplantation. 2021 Oct 1;105(10):e137-e138. doi: 10.1097/TP.0000000000003863.
8
Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration.肾移植受者在首次接种新冠疫苗后很少出现早期抗体反应。
Transplantation. 2021 Jul 1;105(7):e72-e73. doi: 10.1097/TP.0000000000003764.
9
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.移植受者中第三剂mRNA-1273疫苗的随机试验。
N Engl J Med. 2021 Sep 23;385(13):1244-1246. doi: 10.1056/NEJMc2111462. Epub 2021 Aug 11.
10
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.异源ChAdOx1 nCoV-19疫苗和mRNA-1273疫苗接种
N Engl J Med. 2021 Sep 9;385(11):1049-1051. doi: 10.1056/NEJMc2110716. Epub 2021 Jul 14.
引用本文的文献
1
Efficacy of COVID-19 Vaccination in People Living with HIV/AIDS in a Northern Brazil: Cross-Sectional Study.巴西北部艾滋病毒/艾滋病感染者中新冠疫苗接种的效果：横断面研究
Vaccines (Basel). 2025 Mar 7;13(3):283. doi: 10.3390/vaccines13030283.
2
Antibody Response to SARS-CoV-2 Vaccines in Transplant Recipients and Hemodialysis Patients: Data from the Dominican Republic.移植受者和血液透析患者对SARS-CoV-2疫苗的抗体反应：来自多米尼加共和国的数据。
Vaccines (Basel). 2024 Nov 23;12(12):1312. doi: 10.3390/vaccines12121312.
3
Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation.SARS-CoV-2 特异性记忆 B 细胞在增强免疫后促进实体器官移植免疫保护的作用。
Front Immunol. 2024 Oct 8;15:1463769. doi: 10.3389/fimmu.2024.1463769. eCollection 2024.
4
Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study.因新冠肺炎住院的实体器官移植受者的临床结局：一项倾向评分匹配队列研究。
Infect Chemother. 2024 Sep;56(3):329-338. doi: 10.3947/ic.2024.0027. Epub 2024 May 14.
5
COVID-19 pneumonia in lung transplant recipients: understanding risk factors and treatment outcomes in Japan.日本肺移植受者的 COVID-19 肺炎：了解风险因素和治疗结果。
Clin Exp Med. 2024 Jun 10;24(1):123. doi: 10.1007/s10238-024-01388-y.
6
COVID-19 in liver transplant recipients.肝移植受者中的新型冠状病毒肺炎
J Liver Transpl. 2021 Jul-Sep;3:100026. doi: 10.1016/j.liver.2021.100026. Epub 2021 Jul 22.
7
Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients.肾移植受者 COVID-19 疫苗接种后抗受体结合域 IgG 抗体水平与 COVID-19 发病和严重程度的关系。
Viruses. 2024 Jan 12;16(1):114. doi: 10.3390/v16010114.
8
Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review.提高实体器官移植受者中SARS-CoV-2疫苗免疫原性的措施：一项叙述性综述
Vaccines (Basel). 2023 Nov 25;11(12):1755. doi: 10.3390/vaccines11121755.
9
Seroconversion and safety of Covid-19 vaccines in pa-tients with chronic liver disease and liver transplant: A systematic review.新型冠状病毒肺炎疫苗在慢性肝病和肝移植患者中的血清学转换及安全性：一项系统评价。
Qatar Med J. 2023 Dec 12;2023(3):21. doi: 10.5339/qmj.2023.21. eCollection 2023.
10
Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy.接受定制免疫抑制治疗的肝移植受者接种基于SARS-CoV-2 mRNA疫苗后的体液反应评估
J Clin Med. 2023 Nov 3;12(21):6913. doi: 10.3390/jcm12216913.
Zotero 插件